ReviewESC heart failure2018
Acute heart failure management in the USA and Japan: overview of practice patterns and review of evidence.
Review in ESC heart failure, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.
- Circulating galectin-3 on admission and prognosis in acute heart failure patients: a meta-analysis.Heart failure reviews · 2020Pooled it
- Impact of early in-hospital initiation of sacubitril/valsartan on left ventricular reverse remodelling in acute heart failure.European heart journal. Cardiovascular pharmacotherapy · 2025Trial
- Randomized trial to assess worsening renal function by adding dapagliflozin for acute decompensated heart failure.ESC heart failure · 2025Trial
- In-hospital initiation of angiotensin receptor-neprilysin inhibition in acute heart failure: the PREMIER trial.European heart journal · 2024Trial
- Efficacy and safety of intravenous OPC-61815 compared with oral tolvaptan in patients with congestive heart failure.ESC heart failure · 2022Trial
- Novel enhancers of guanylyl cyclase-A activity acting via allosteric modulation.British journal of pharmacology · 2023Article
- Natriuretic Peptides: It Is Time for Guided Therapeutic Strategies Based on Their Molecular Mechanisms.International journal of molecular sciences · 2023Review
- Diagnostic utility of lung echography for congestive heart failure performed by junior resident doctors.Journal of general and family medicine · 2022Article
- Sacubitril/valsartan in Heart Failure and Beyond-From Molecular Mechanisms to Clinical Relevance.Reviews in cardiovascular medicine · 2022Review
- Temporal changes and prognostic value of plasma ghrelin level in patients with acute heart failure: a prospective study.Heart and vessels · 2022Article
- Clinical implication of initial intravenous diuretic dose for acute decompensated heart failure.Scientific reports · 2022Article
- Ultrafiltration in Japanese critically ill patients with acute kidney injury on renal replacement therapy.Journal of intensive care · 2021Article
- Pathophysiology and Therapeutic Approaches to Acute Decompensated Heart Failure.Circulation research · 2021Review
- Acute heart failure management in the USA and Japan: overview of practice patterns and review of evidence.ESC heart failure · 2018Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 4 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Globally, acute heart failure (AHF) remains an ongoing public health issue with its prevalence and mortality increasing in the east and the west. Effective treatment strategies to stabilize AHF are important to alleviate clinical symptoms and to improve clinical outcomes. However, despite the progress in the management of stable and chronic heart failure, no single agent has been proven to play a definitive role in the management of AHF. As a consequence, contemporary treatment strategies for patients with AHF vary greatly by region. This manuscript reviews the medical treatment options for AHF, with an emphasis on the differences between the treatment strategies in the USA and Japan. This information would provide a framework for clinicians to evaluate and manage patients with AHF and highlight the remaining questions to improve clinical outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.